STTK

NASDAQStock

Shattuck Labs, Inc.

$6.00+0.14 (+2.30%)

52-Week Range

$0.73

$6.13

Key Stats

Market Cap

287.4M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.67

Volume

310.2K

Avg Volume

786.7K

Performance

+49.88%

+100.33%

+242.46%

YTD

+65.23%

+406.61%

+113.59%

-83.95%

Price Chart

ETF Exposure

STTK is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
CNCR	Loncar Cancer Immunotherapy ETF	3.23%	53,960	$867K	$12.7M	0.79%
QQQS	Invesco NASDAQ Future Gen 200 ETF	1.37%	31,534	$188K	$13.8M	0.20%
PQSG	PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF	0.17%	883	$22K	$13.0M	N/A
AVSC	Avantis U.S. Small Cap Equity ETF	0.01%	43,402	$259K	$2.37B	0.25%
STSB	iShares Factors US Small Blend Style ETF	0.01%	33	$615	$7.3M	0.35%
VXF	Vanguard Extended Market ETF	0.00%	606,782	$2.3M	$84.10B	0.05%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	2,719	$16K	$41.36B	0.17%
VTI	Vanguard Total Stock Market ETF	0.00%	1,591,107	$6.2M	$2.10T	0.03%

About STTK ETF Exposure

Shattuck Labs, Inc. (STTK) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 287.4M, STTK is a widely held institutional stock. The stock currently trades at $6.00. Investors can gain exposure to STTK through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold STTK, sorted by portfolio weight.